1. Home
  2. YSXT vs SLS Comparison

YSXT vs SLS Comparison

Compare YSXT & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSXT
  • SLS
  • Stock Information
  • Founded
  • YSXT 2011
  • SLS 2012
  • Country
  • YSXT China
  • SLS United States
  • Employees
  • YSXT N/A
  • SLS N/A
  • Industry
  • YSXT Automotive Aftermarket
  • SLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSXT Consumer Discretionary
  • SLS Health Care
  • Exchange
  • YSXT Nasdaq
  • SLS Nasdaq
  • Market Cap
  • YSXT 79.2M
  • SLS 89.6M
  • IPO Year
  • YSXT 2024
  • SLS N/A
  • Fundamental
  • Price
  • YSXT $4.52
  • SLS $1.40
  • Analyst Decision
  • YSXT
  • SLS
  • Analyst Count
  • YSXT 0
  • SLS 0
  • Target Price
  • YSXT N/A
  • SLS N/A
  • AVG Volume (30 Days)
  • YSXT 52.5K
  • SLS 1.3M
  • Earning Date
  • YSXT 02-24-2025
  • SLS 05-13-2025
  • Dividend Yield
  • YSXT N/A
  • SLS N/A
  • EPS Growth
  • YSXT N/A
  • SLS N/A
  • EPS
  • YSXT 0.18
  • SLS N/A
  • Revenue
  • YSXT $66,143,276.00
  • SLS N/A
  • Revenue This Year
  • YSXT N/A
  • SLS N/A
  • Revenue Next Year
  • YSXT N/A
  • SLS N/A
  • P/E Ratio
  • YSXT $27.40
  • SLS N/A
  • Revenue Growth
  • YSXT 21.23
  • SLS N/A
  • 52 Week Low
  • YSXT $2.06
  • SLS $0.77
  • 52 Week High
  • YSXT $6.27
  • SLS $1.84
  • Technical
  • Relative Strength Index (RSI)
  • YSXT N/A
  • SLS 72.02
  • Support Level
  • YSXT N/A
  • SLS $1.29
  • Resistance Level
  • YSXT N/A
  • SLS $1.38
  • Average True Range (ATR)
  • YSXT 0.00
  • SLS 0.09
  • MACD
  • YSXT 0.00
  • SLS 0.03
  • Stochastic Oscillator
  • YSXT 0.00
  • SLS 86.54

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: